entertainment -WSS

entertainment

author：knowledge 2025-10-03 00:08:00 - browse：34

Adam's take main illustration — Molly Ferguson/STAT

Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not close. Six months from now, or sooner, Novartis will walk away — slightly embarrassed but otherwise unscathed — happy to pay a small breakup fee to MorphoSys to avoid owning a drug for myelofibrosis that regulators turned away.

MorphoSys will not fare as well from the breakup. Its future, and that of the drug called pelabresib at the center of the deal, will be thrown into limbo.

This is all speculation on my part, but it’s supported by separate conversations with two people familiar with pelabresib and the debate inside Novartis over the MorphoSys acquisition. They requested anonymity to discuss confidential matters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： The biotech scorecard for Q4: 16 stock

WSS

Close Medicare's dangerous gaps in addiction treatment coverage

Experts study whether long Covid risk adds up with each reinfection

Diversity in clinical trials starts with building trust, experts say

WHO recommends second malaria vaccine

The Karikó problem: Lessons for funding basic research

Flu, Covid vaccination rates decline, new survey data show

entertainment

entertainment

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Element Biosciences CEO lays out genome sequencing strategy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Element Biosciences CEO lays out genome sequencing strategy

In Memoriam: Notable people who died in 2023

New oral drug delivery patch is modeled after octopus tentacles

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Novavax promises a turnaround & Lilly roils the obesity market

RSV injection headlines need to be accurate for good uptake

knowledge

Bird flu outbreak in cows is latest avian flu curveball

Will an HIV vaccine ever be a reality?

The United States is paying nearly triple for new Covid vaccines

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

MassMutual is introducing free genetic testing for members

Why does health care cost so much? A reading guide

explore

focus

hotspot

Wikipedia